As we approach the 2024 Senate elections in Pennsylvania, it is essential that we rally behind the Democratic candidate who has proven his commitment to the people of the state time and time again. That candidate is none other than Bob Casey.

Bob Casey has been a strong voice for the people of Pennsylvania since he was first elected to the Senate in 2006. He has fought tirelessly to protect the rights of working families, support small businesses, and promote economic growth across the state. He has been a champion of healthcare reform, advocating for accessible and affordable healthcare for all Pennsylvanians.

Throughout his years in the Senate, Bob Casey has consistently prioritized the needs of his constituents over partisan politics. He has worked across the aisle to find common ground and pass legislation that benefits the people of Pennsylvania. He has also been a vocal advocate for women's rights, LGBTQ+ rights, and civil rights.

As we look towards the future, it is crucial that we have leaders like Bob Casey in the Senate. He has proven time and time again that he has the experience, dedication, and passion to fight for the people of Pennsylvania and make a real difference in their lives.

So, let's come together and
show our support for Bob Casey as he runs for Senate in 2024. Together, we can
ensure that our voices are heard and that Pennsylvania continues to have a
strong and effective leader in the Senate.

Show your support for this campaign by endorsing it and sharing why!

Endorse

July 11, 2024

Casey Holds Hearing on Lowering Health Care Costs

At Aging Committee hearing, Casey touted his Capping Prescription Costs Act Casey’s new bill would lower prescription drug costs for millions of Americans Washington, D.C. - Today, U.S. Senator Bob Casey (D-PA), Chairman of the U.S. Senate Special Committee on Aging, held a hearing highlighting his efforts to lower health care costs for American patients. At the hearing, entitled “Health Care Transparency: Lowering Costs and Empowering Patients,” Senator Casey touted his new Capping Prescription Costs Act, which would bring down prescription costs for millions of Americans. “Prescription drug costs are like a bag of rocks tied around the necks of millions of Americans, weighing them down every single day, and Congress has a responsibility to lessen that weight,” said Chairman Casey (D-PA). “We have made a lot of progress on health care costs over the last few years, particularly by passing the Inflation Reduction Act, which is capping prescription drug costs for Medicare Part D beneficiaries. My new bill will extend those savings to the millions of Americans who have private insurance.” Chairman Casey has long been a leader in the Senate’s efforts to bring down prescription drug costs. In August 2022, Casey fought to pass the Inflation Reduction Act (IRA) to lower health care and prescription drug costs for older adults, people with disabilities, and families across the Nation. Starting in January 2023, the IRA capped the cost of insulin for Medicare Part D beneficiaries at $35 a month for certain covered insulin products. The law also will limit Medicare beneficiaries’ out-of-pocket costs at $2,000 per year beginning in 2025. Casey’s new bill will extend that out-of-pocket cost cap to the commercial health care market. The new $2,000 cap on cost-sharing for individuals and $4,000 for families will apply to all of the 173 million Americans who have private health insurance. Read more about the Capping Prescription Costs Act here.

Back to all updates

Show your support for this campaign by endorsing it and sharing why!

Endorse